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Patients seen in genetics clinics often endure a diagnostic odyssey in their search 
for answers for their medical symptoms. This time is not only challenging for patients 
and their families, but also for the genetic counselors who are trying to help the patients. 
Previous research has shown that parents of children with undiagnosed medical disorders 
have specific goals and reasons for wanting to find a diagnosis, and there are many 
difficulties faced by these parents. Genetic counselors often serve as a prominent figure 
during the diagnostic odyssey, but little known research has assessed the current practices 
of and impact that the diagnostic odyssey has on genetic counselors. This study surveyed 
pediatric genetic counselors to assess their current practices and thoughts about the 
diagnostic odyssey. This was assessed utilizing a questionnaire, which included both 
multiple choice and short answer questions. We identified current genetic counseling 
practices including communication methods and resources provided to patients. 
Counselors reported a possible need to share the responsibility of communication with 
their patients and a lack of resources specific to patients on the diagnostic odyssey. 
Genetic counselors also reported feeling personally impacted by patients on the 
diagnostic odyssey, and described the positive and negative feelings they experience, in 
addition to strategies to cope with their frustrations. In conclusion, the diagnostic odyssey 
is a complex process for patients, and similarly challenging for the counselors who are 
involved in the patients’ care. Genetic counselors have an opportunity to provide 
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additional support, resources, and hope to families during the diagnostic odyssey, 
although these roles may not be strictly defined in the counselors’ responsibilities.   
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Chapter 1: Background 
1.1 What is a Diagnosis? 
 
In medicine, and especially genetics, making a “diagnosis” can mean a variety of 
different things. Some disorders are readily identifiable and a diagnosis can be made 
shortly after symptoms present. However, certain patients with genetic disorders 
experience a prolonged period of time before receiving a diagnosis because their 
symptoms and features may not represent a commonly identifiable disorder or syndrome 
with a known etiology. 
Physicians utilize a few different types of diagnoses in order to provide one name 
to encompass a patient’s symptoms. One type of diagnosis can be considered 
“descriptive” or clinical. This means that one name has been given for a grouping of 
features, but there may or may not be a known underlying reason for the disorder 
(Makela, Birch, Friedman, & Marra, 2009). One example of a disorder with only a 
descriptive diagnosis is autism. There is little known about the biological cause for 
autism, but researchers have created criteria that can be used to identify a patient as 
having autism (American Psychiatric Association, 2013). Descriptive diagnoses may also 
include an “etiological” or “molecular” diagnosis. These types of diagnoses have not only 
a name, but also a known molecular or biological cause. These disorders may have been 
more extensively researched and have an established natural history with prognostic 
information. It is possible to only have a molecular or etiological diagnosis, meaning that 
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genetic testing has been performed and a deleterious mutation has been identified, but 
healthcare professionals may not know the full effects of the mutation and may not be 
able to make predictions about the progression of symptoms. These disorders may only 
be identified by the genetic mutation and may not be recognizable to the general public 
by name because of the rarity of the finding (Makela et al., 2009). Finally, a patient 
without a clinical or molecular diagnosis may receive a “working” diagnosis, or a 
suggestion of a type of disorder that seems to be present but cannot be specifically 
identified (Lewis, Skirton, & Jones, 2010). This can be useful when a patient’s group of 
symptoms does not meet diagnostic criteria for a specific condition, or a specific 
molecular cause was not found or has not yet been discovered. 
1.2 The Diagnostic Odyssey and Uncertainty 
  
Many patients seen in genetics clinics experience a diagnostic odyssey, or “the 
time between when a parent or provider first becomes concerned about a child’s 
development and a diagnosis is eventually reached” (Carmichael, Tsipis, Windmueller, 
Mandel, & Estrella, 2015, p. 326). For some patients, this odyssey does not have a 
concrete ending because neither a descriptive nor etiological diagnosis can be made. The 
amount of time spent on the odyssey can vary, possibly extending over a lifetime. It has 
been reported that up to 50% of all cases of intellectual disability do not have a known 
etiology and therefore, families continue an extended diagnostic odyssey (Daily, 
Ardinger, & Holmes, 2000). Additionally, Shashi et al. (2013) reported that “the rate of 
unidentified genetic conditions is conventionally thought to be 50% overall, [but] there 
are surprisingly few empirical data supporting this statistic” (p. 176). 
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The diagnostic odyssey is a time of uncertainty for patients and their families as 
they try to plan for the future and manage the apparent symptoms (Rosenthal, Biesecker, 
& Biesecker, 2001). The amount of uncertainty may also be influenced by the interaction 
with healthcare professionals who must discuss the unknowns of the condition (Jessop & 
Stein, 1985). Some parents of children without a diagnosis have described their 
experience as stressful due to the added care for the children and required medical 
appointments. Additionally, parents experienced other psychological problems, including 
emotional distress and burden, due to the difficulties of not having a diagnosis. These 
difficulties often originated from feelings of being out of control. (Lewis et al., 2010) 
In addition to stress, uncertainty often takes away the sense of control for parents. 
Madeo, O’Brien, Bernhardt, and Biesecker, (2012) assessed this uncertainty and lack of 
control in parents with children having different medical conditions, some of whom were 
undiagnosed. Individuals who perceived less control over their child’s undiagnosed 
condition reported less optimism and higher uncertainty. These individuals felt they did 
not have control over the disease, their future, and medical care. However, they did feel 
in control of some aspects of their child’s condition, including information and decision 
making, advocacy, the child’s comfort, and self-care. (Madeo et al., 2012) 
1.3 Parental Value of a Diagnosis 
  
Several themes have been identified as parental benefits of having a diagnosis. 
These themes include having a label for the child’s condition, being able to predict the 
course of the disorder and provide a prognosis, accepting and validating the parents’ 
concerns, and having access to support networks (Carmichael et al., 2015; Lewis et al., 
2010; Makela et al., 2009; & Rosenthal et al., 2001). In terms of support services, parents 
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identified support from other parents in a similar situation as a useful source; the match 
between parents is critical (Ainbinder et al., 1998). Unfortunately, it is difficult to 
identify parents in similar situations when there is not one unifying term to describe the 
situation. 
A limited number of studies have assessed the perceptions of parents whose 
children do not have a diagnosis for their collection of symptoms. Interviews with parents 
of children with neuromuscular disorders found that, during the diagnostic odyssey, 
parents desired a diagnosis for validation, a prognosis in order to plan for the future, and 
access to specific support networks (Carmichael et al., 2015). Providing a label for the 
child’s condition proved essential for obtaining services and support for the affected 
children.  Interviews with parents whose children have multiple congenital anomalies 
revealed similar themes and motivations for obtaining a diagnosis for their child’s 
medical condition (Rosenthal et al., 2001). In addition to having a “label” and prognosis 
for the condition, parents expressed concern for recurrence in future children and a need 
to know as much information as they could about the condition. Parents expressed 
understanding that having a particular diagnosis may not have a cure and may not change 
their current medical management, but recognized the importance for future medical 
research (Rosenthal et al., 2001).  
A study conducted in the United Kingdom in 2010 (Lewis et al.) analyzed 
interviews with parents of children who had an undiagnosed condition and had been seen 
in a genetics clinic. Parents most often stated that they wanted a diagnosis for “help with 
care and treatment” and “to know about the future.” In addition, parents discussed 
wanting a label to use with the public when discussing the cause for their child’s 
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condition. Certain parents utilized “social diagnoses,” similar to the earlier discussed 
descriptive diagnoses, to generally explain their child’s medical problem to society. One 
parent commented that the idea of a “working” diagnosis might provide similar insight 
for the patient and their family as when having a descriptive diagnosis (Lenhard, 
Breitenbach, Ebert, Schindelhauer-Deutscher, & Henn, 2005). With a working diagnosis, 
the patient and their family may be able to access support groups and obtain services that 
might not otherwise be available without a diagnosis (Lenhard et al., 2005). Similarly, 
parents whose children have undergone molecular testing hoped to find an answer in 
order to help explain their child’s condition, better prepare for the future, and better 
manage their child’s care (Sapp et al., 2014). 
Most studies that interviewed parents of children with undiagnosed medical 
conditions found that parents wanted more support options and thought there was a lack 
of support when no diagnosis was found (Carmichael et al., 2015; Lewis et al., 2010; 
Rosenthal et al., 2001). One support organization has been identified as focusing 
specifically on undiagnosed patients, titled “Syndromes Without A Name (SWAN).” This 
group was organized in 2004 in the United States to provide support and information to 
families who were affected by an unknown medical syndrome (SWAN USA, 2014). 
SWAN also directs families to potential clinical trials and studies that may help them find 
a diagnosis for their child’s condition. Previous studies involving parents of undiagnosed 
children indicated that these parents felt a lack of support and may not have been aware 
of nation-wide support groups such as SWAN. There may also be local organizations that 
serve as “special needs groups” that may provide support to families and aid in 
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navigating state services, but these are not specific to a particular diagnosis or lack 
thereof. 
1.4 Incorporation of New Technologies and Discoveries into Practice 
 
Strides are continuing to be made in genetic research and testing to be able to 
provide more information about genetic disorders and increase diagnostic yield. As new 
technologies have been developed, practice guidelines have changed to reflect the most 
effective use of these developments. For example, in 2010, chromosomal microarray 
became a first-tier test for patients with developmental delay, intellectual disability, 
autism spectrum disorders, and multiple congenital anomalies (Miller et al., 2010). Since 
the development of the microarray test, Next Generation sequencing has become another 
technological development that has improved the overall utility of genetic testing. Next 
Generation sequencing allows for rapid sequencing of single and multiple genes at a 
reduced cost compared to traditional Sanger sequencing (Mardis, 2008). The innovation 
of Next Generation sequencing has allowed for continued discovery of novel genes, 
providing etiologies for previously undiagnosed medical conditions. Next Generation 
sequencing is currently being used in Whole Exome Sequencing (WES), sequencing 
nearly all of the coding exons within the genome, and Whole Genome Sequencing 
(WGS), which includes the additional non-coding regions of the genome (Yang et al., 
2014). As new tests are developed and become more accessible, there is a growing 
opportunity to incorporate technological advances into clinical use to identify a genetic 
etiology for a patient’s medical condition. 
Genetics professionals must continue to adapt with the ever-developing landscape 
of genetic technology. Lazaridis et al. (2014) reported one example of an institutional 
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approach to new genetic technology that came from the Mayo Clinic. They have created 
an Individualized Medicine Clinic to incorporate genomic technological advances into 
everyday clinical practice. One of the services offered by this clinic is WES for patients 
during their diagnostic odyssey. This service includes determining if the patient would 
benefit from WES, having an extensive genomic counseling session, and interpreting the 
results from sequencing by a review board. The clinic utilizes a “Genomic Odyssey 
Board” to interpret the results and make recommendations to the referring physician. 
After a year of offering this service, the researchers determined that patients need an 
extended conversation with a genetic counselor in order to grasp the abilities of genomic 
testing. However, no diagnostic rates from this year of service were provided (Lazaridis 
et al., 2014). 
In recent years, more genetics clinics are ordering WES for their patients with 
complex medical conditions and various laboratories that offer this testing are starting to 
report their diagnostic rates and findings from WES. Yang et al. (2014) reported a 
molecular diagnostic rate of 25.2% from Baylor College’s first 2,000 exomes sequenced, 
similar to Ambry Genetics’ first 500 exomes sequenced, which resulted in a 30% 
molecular diagnostic rate (Farwell et al., 2014). Lee et al. (2014) reported a molecular 
diagnostic rate of 26% at the University of California, Los Angeles, and Sawyer et al. 
(2015) reported a diagnostic rate of 23-34% using WES for the Canadian group called 
Finding of Rare Disease Genes (FORGE). The previously listed studies reported higher 
diagnostic rates when three family members contributed DNA for sequencing, 
specifically the patient and two first-degree relatives. Many WES tests identified novel 
genes or variants that were predicted to be pathogenic or likely pathogenic. In addition to 
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finding new genes, many of the genes that were found to have damaging mutations were 
discovered in the last few years and may not be included yet in single gene or panel tests 
(Farwell et al., 2014; Lee et al., 2014; Yang et al., 2014). 
While these studies have shown a benefit to utilizing WES as a diagnostic tool in 
genetics clinics, they also have shown that this technology is often not the final chapter in 
a patient’s diagnostic odyssey. These studies demonstrated that WES is able to find a 
disease-causing mutation in around 25-30% of patients, leaving up to 75% of genetics 
patients to continue on their diagnostic odyssey. While WGS is possible as well, it is not 
utilized as frequently and results in a greater amount of data that requires analysis and 
interpretation. One of the downsides of genomic medicine is that there are a greater 
number of results of variants of uncertain significance that may or may not be causal of 
the patient’s condition and this can complicate an already stressful situation (Rosell et al., 
2016). 
Of the 25-30% of patients who are receiving molecular diagnoses, there may still 
be little known about the prognosis of the condition. In this way, a finding from WES 
may not provide the information that may benefit a patient and their family. In a study 
published by Makela et al. (2009), patients expressed that a descriptive diagnosis may be 
more beneficial than a genetic diagnosis. Often times, a descriptive diagnosis provides 
information based on the natural history of the disorder as seen from many clinical cases 
of the same diagnostic features. Although these disorders may not have a known genetic 
etiology, they may have established support groups and specialists who know the 
disorder well and are able to provide the prognostic information that patients seem to be 
pursuing. 
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There has been limited research that explores parents’ opinions about the process 
of WES. More recently, Rosell et al. (2016) reported perceptions of parents after 
concluding the WES process for their undiagnosed child. Many of these parents had the 
experience of identifying a definite or likely cause for their child’s medical symptoms, 
while few had the experience of identifying a VUS or no diagnosis at all from WES. 
Parents expressed varying views regarding their expectations and concerns about WES, 
but most expressed hope in finding an answer and being able to connect with other 
families with the same genetic diagnosis. Parents were also able to recall the details of the 
testing itself and understood the different results, and many felt that the definite or likely 
diagnoses were beneficial in terms of improving their child’s medical management, 
understanding their child and the condition, and increasing their hope for the future 
(Rosell et al., 2016). 
1.5 Genetic Counselors’ Role in the Diagnostic Odyssey 
 
As has been mentioned above, genetic counselors play a prominent role in 
assisting families with their diagnostic odyssey. According to the National Society of 
Genetic Counselors (NSGC) website: 
Genetic counseling is a process of helping people understand and adapt to the 
medical, psychological and familial implications of genetic contributions to 
disease. This process integrates: 
• Interpretation of family and medical histories to assess the chance of 
disease occurrence or recurrence. 
• Education about inheritance, testing, management, prevention, resources 
and research. 
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• Counseling to promote informed choices and adaptation to the risk or 
condition. (National Society of Genetic Counselors, 2015) 
When a patient does not have a diagnosis, this process may be altered. For instance, 
without a molecular diagnosis, the counselors may be limited in their ability to provide 
information about recurrence in future pregnancies or for occurrence in other family 
members. They may experience limitations in educating the patient about inheritance of 
the disorder or providing disease-specific resources. Finally, the lack of information may 
impact the counselors’ ability to promote adaptation to the condition because they have 
limited information about the prognosis or natural history. 
Although challenges exist to the genetic counseling process when a diagnosis is 
unknown, genetic counselors can implement other strategies in order to achieve the goals 
of a session. In Lipinski, Lipinski, Biesecker, and Biesecker, (2006), parents of children 
in genetics clinics were interviewed to identify helpful qualities of a genetic counselor 
and to identify suggestions to improve the genetic counseling session. Parents who felt 
that the genetic counselor was helpful seemed to benefit from interventions that helped 
them gain a sense of control over their situation. When there was greater uncertainty, the 
parents found the genetic counselor less helpful. Parents suggested that counselors 
provide more information and resources but parents also understood there may not be 
much information available. Therefore, the authors concluded that addressing the lack of 
information is an important strategy for genetic counselors. It could also be helpful for 
the counselor to ask the parents what they need regarding the condition. The parents 
emphasized that the providers should remain available and they wanted to be informed 
	 11 
when new information became available to the genetics professionals (Lipinski et al., 
2006). 
Genetic counselors can also assist parents with identifying factors over which 
they do have control in situations of medical uncertainty. These factors may include 
providing effective coping strategies, encouraging advocacy for their child, and giving 
control in making decisions regarding the child’s medical care (Madeo et al., 2012). 
Some coping strategies that parents have identified as being beneficial include creating 
future images, seeking social support, and identifying positive aspects, all of which 
genetic counselors are able to do (Graungaard & Skov, 2007). In addition to these 
specific strategies, pediatric genetic counselors often play a larger role in the diagnostic 
odyssey. At the Individualized Medicine Clinic at the Mayo Clinic, genetic counselors 
often became the patient’s main point of contact (Lazaridis et al., 2014). Therefore, the 
relationship between the patient, their family, and pediatric genetic counselors is critical 
throughout the diagnostic odyssey. 
Due to this primary role that genetic counselors play in the diagnostic odyssey, 
they were selected as the main subjects for this study. We aimed to establish the clinical 
and personal impact of the diagnostic odyssey on pediatric genetic counselors. We 
investigated the information and resources that genetic counselors offer to their patients 
who are on a diagnostic odyssey. Also of interest were the counselor’s preferences for a 
molecular or descriptive diagnosis and their utilization of new technologies for clinical 
patients. We compared genetic counselor’s offerings to parents’ reports of needs and 
desired resources. 
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We hypothesized the following: first, that genetic counselors are utilizing similar 
strategies in their current practice for all patients, including those without a diagnosis; 
second, that counselors would agree with themes previously reported by parents in the 
literature, including the challenges of not having a diagnosis and the limited availability 
of resources and support options; third, that pediatric genetic counselors would identify 
strategies and resources that have seemed beneficial to parents of children on a diagnostic 
odyssey; and finally, that patients on a diagnostic odyssey would have a personal impact 
on genetic counselors.  
A questionnaire was sent to pediatric genetic counselors through the NSGC 
electronic mailing list. The questionnaire consisted of multiple choice, open-ended, and 
Likert Scale questions created by the researchers and adapted from themes expressed in 
the literature. The participants remained anonymous; no identifying information was 
collected on the survey. There was no immediate benefit to the survey participants, but 
we hope to provide future suggestions that may be beneficial in genetics clinics. 
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Chapter 2: The Undiagnosed Patient and the Diagnostic Odyssey: 
Current Genetic Counseling Practices and Perspectives1 
 
2.1 Abstract 
Patients seen in genetics clinics often endure a diagnostic odyssey in their search 
for answers for their medical symptoms. This time is not only challenging for patients 
and their families, but also for the genetic counselors who are trying to help the patients. 
Previous research has shown that parents of children with undiagnosed medical disorders 
have specific goals and reasons for wanting to find a diagnosis, and there are many 
difficulties faced by these parents. Genetic counselors often serve as a prominent figure 
during the diagnostic odyssey, but little known research has assessed the current practices 
of and impact that the diagnostic odyssey has on genetic counselors. This study surveyed 
pediatric genetic counselors to assess their current practices and thoughts about the 
diagnostic odyssey. This was assessed utilizing a questionnaire, which included both 
multiple choice and short answer questions. We identified current genetic counseling 
practices including communication methods and resources provided to patients. 
Counselors reported a possible need to share the responsibility of communication with 
their patients and a lack of resources specific to patients on the diagnostic odyssey. 
Genetic counselors also reported feeling personally impacted by patients on the 
diagnostic odyssey, and described the positive and negative feelings they experience, in  
 
1Wardyn, A., Jordon, E., Corning, K., & Carmichael, N. To be submitted to Journal of Genetic Counseling
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addition to strategies to cope with their frustrations. In conclusion, the diagnostic odyssey 
is a complex process for patients, and similarly challenging for the counselors who are 
involved in the patients’ care. Genetic counselors have an opportunity to provide 
additional support, resources, and hope to families during the diagnostic odyssey, 
although these roles may not be strictly defined in the counselors’ responsibilities.  
2.2 Introduction 
Many patients seen in genetics clinics experience a diagnostic odyssey, or “the 
time between when a parent or provider first becomes concerned about a child’s 
development and a diagnosis is eventually reached” (Carmichael et al., 2015, p. 326). The 
diagnostic odyssey is a time of uncertainty for patients and their families as they try to 
plan for the future and manage the apparent symptoms (Rosenthal et al., 2001). Parents 
benefit from having a diagnosis in several ways, including having a label for the child’s 
condition, being able to predict the course of the disorder and provide a prognosis, 
acceptance and validation of the parents’ concerns, and having access to support 
networks (Carmichael et al., 2015; Lewis et al., 2010; Makela et al., 2009; Rosenthal et 
al., 2001). Genetic counselors play a prominent role in assisting families with their 
diagnostic odyssey by helping them feel more in control of their situation and helping 
them cope with the uncertainty of not having a diagnosis (Lipinski et al., 2006; Madeo et 
al., 2012). 
Continuing strides in genetic research and testing increase the information 
available to families. Improved testing not only increases our knowledge of genetic 
disorders, but also increases diagnostic yield. Geneticists in pediatric clinics are more 
often ordering chromosomal microarray and whole exome sequencing (WES) for their 
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patients with complex medical conditions in order to identify a genetic diagnosis. These 
tests are non-specific and often unveil new or unexpected diagnoses. Studies show that 
WES is able to find a disease-causing mutation in around 25-30% of patients, leaving up 
to 75% of genetics patients who still must continue on their diagnostic odyssey (Farwell 
et al., 2014; Lee et al., 2014; Yang et al., 2014). Of those who receive a molecular 
diagnosis, many may not have extensive prognosis and natural history research available 
to provide the type of information that parents are seeking (Makela et al., 2009). 
Little research has been conducted to assess the feelings and experiences of 
genetics patients who have not obtained a diagnosis, and no research to our knowledge 
has been conducted to assess the feelings and experiences of the healthcare professionals 
involved with these families. This population may make up a significant portion of the 
patients seen in clinics, and there are currently no guidelines or recommendations for 
counseling patients who do not receive a diagnosis. However, previous studies 
(Carmichael et al., 2015; Lewis et al., 2010; Rosenthal et al., 2001) have shown that 
parents of these patients do want and need similar resources and information for their 
child during the diagnostic odyssey.  
Genetic counselors were the focus of this study because they play a primary role 
in the assessment of patients in genetics clinics and often become the point of contact for 
the patient through the genomic process and diagnostic odyssey (Lazaridis et al., 2014). 
We aimed to establish the clinical and personal impact of the diagnostic odyssey on 
pediatric genetic counselors. We investigated the information and resources that genetic 
counselors offer to their patients who are on a diagnostic odyssey. Also of interest were 
the counselor’s preferences for a molecular or descriptive diagnosis and their utilization 
	 16 
of new technologies for clinical patients. We compared the genetic counselor’s offerings 
to parents’ reports of needs and desired resources. 
We hypothesized the following: first, that genetic counselors are utilizing similar 
strategies in their current practice for all patients, including those without a diagnosis; 
second, that counselors would agree with themes previously reported by parents in the 
literature, including the challenges of not having a diagnosis and the limited availability 
of resources and support options; third, that pediatric genetic counselors would identify 
strategies and resources that have seemed beneficial to parents of children on a diagnostic 
odyssey; and finally, that patients on a diagnostic odyssey would have a personal impact 
on genetic counselors.  
2.3 Materials and Methods 
An invitation to take part in our survey was sent via email to genetic counselors 
who are current members of the NSGC (see Appendix A). The selection process for 
participation was based on individuals who identified themselves as pediatric genetic 
counselors. The email was sent through the NSGC electronic mailing list on Wednesday 
July 22, 2015 and again on Tuesday September 1, 2015.  
The inclusion criteria were as follows: 
• currently practicing as a genetic counselor and currently counseling at 
least 30% clinical pediatric cases; 
• counseling at least 10% undiagnosed patients. 
The exclusion criteria were as follows: 
• genetics professionals other than genetic counselors; 
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• currently practicing genetic counselors who see less than 40% clinical 
pediatric cases; 
• and/or have less than 10% undiagnosed patients. 
Participants were first asked to read the Participant Introductory Letter (see 
Appendix B) and then could continue to take our online questionnaire (see Appendix C). 
The questionnaire assessed the current practices of pediatric genetic counselors when 
seeing a patient who is on a diagnostic odyssey. We provided the following definition of 
a diagnosis and the diagnostic odyssey: 
Providers working in pediatric genetics clinics may make diagnoses in a 
number of different ways, such as based on clinical symptoms or genetic 
testing. For the purposes of this survey, we are focusing on patients on a 
diagnostic odyssey. These patients have a collection of symptoms that the 
medical team believes to be related, but a single unifying cause or 
descriptive label has not been identified. The patients may be collectively 
referred to as “undiagnosed”. 
The questionnaire consisted of items including demographic information, Likert 
Scale questions, multiple choice questions, and open-ended questions (see Appendix C). 
The participants remained completely anonymous; no identifying information was 
collected on the survey. There was no immediate benefit to the survey participants, but 
we hope to provide future suggestions that may be beneficial in counseling pediatric 
genetics patients. There was also no risk to participants of completing the survey. This 
research study was approved by the Institutional Review Board, Office of Research 
Compliance, of the University of South Carolina in June, 2015. 
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We expected to determine the goals of genetic counselors when working with this 
population as well as the impact that these patients have on the counselor. We also aimed 
to compare themes among pediatric genetic counselors to those seen among parents of 
children without a diagnosis described in the literature. To address these research goals, 
we used descriptive statistical analysis using Microsoft Office Excel software. The 
majority of survey items resulted in categorical information and therefore percentages 
and frequencies were calculated, in addition to utilizing the Chi-Square Test for 
Independence to analyze associations between categorical variables.  
For the responses collected from open-ended questions, we used grounded theory 
methods to analyze the qualitative data. There were no preset themes for our study’s 
focus. The primary investigator identified and coded apparent themes from the 
participants’ responses and reported on their frequency below. 
2.4 Results 
A total of 77 questionnaires were collected. Seven were removed for not meeting 
the inclusion criteria of seeing at least 30% pediatric patients or at least 10% undiagnosed 
patients. Seven other questionnaires were removed due to not being completed. Our 
analyses included the remaining 63 questionnaires described below.  
The participants’ demographics can be found in Table 2.1. The majority of 
participants were female, Caucasian, and reported that at least 30% of their pediatric 
patients were undiagnosed. There was a wide range of experience represented and most 




Table 2.1 Participant Demographics (N = 59) 



















































































































2.4.1 Definition of the diagnostic odyssey. Participants were first asked to provide 
their own definition of the diagnostic odyssey. Most participants (n = 62, 98%) provided 
their own definition, which was generally similar to the definition that has been discussed 
in the literature and was provided in the questionnaire. The following themes were 
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identified: patients included those with an unknown underlying cause for their medical 
symptoms; the complex diagnostic workup including numerous tests, imaging, 
procedures, and specialists; and the lack of a specific timeframe ranging from months to 
years. 
2.4.2 Current communication practices. Participants were asked about their 
current communication practices with pediatric patients, including if they have a method 
of recording undiagnosed patients for future identification and how they incorporate new 
technologies into practice for undiagnosed patients. Only about a third of participants (n 
= 23, 37%) reported having a method of recording undiagnosed patients for future 
identification in their clinic. Of those who did not have a method of recording patients 
and their diagnosis, about half (n = 18, 45%) believed that they needed a method. 
Participants were asked how they and their colleagues incorporate new 
technologies into practice for undiagnosed patients. Results are shown in Figure 2.1. Of 
the 25 participants who commented on the method(s) they use to record undiagnosed 
patients for future identification, 12 (48%) discussed scheduling follow-up appointments 
as their main method for tracking undiagnosed patients and 14 (56%) reported having a 
database or spreadsheet of all pediatric patients with their diagnosis, or lack thereof, 
recorded for reference. Nearly half (n = 26, 41%) of participants thought that another 
method of communication for sharing new tests or novel discoveries would better benefit 
patients on the diagnostic odyssey. 
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Figure 2.1 Methods for incorporating new technologies into practice for undiagnosed 
patients. 
 
From the 25 participants who suggested other methods of communication that 
might benefit patients on their diagnostic odyssey, the predominant theme was utilizing 
electronic modes such as secure email or patient portals, e-blasts and newsletters, or 
social media (n = 14, 56%). A second theme was the difficulty of communication and 
follow-up due to a lack of staff to manage the large quantity of patients and time required 
to contact them (n = 5, 20%). Four participants believed that is not the responsibility of 
the healthcare team to reach out to patients between appointments, regardless of updates 
to testing or information. 
2.4.3 Most important aspects of a genetic counseling session. Participants 
compared the most important aspects of genetic counseling sessions for undiagnosed and 
diagnosed patients. These two patient populations assessed aspects of genetic counseling 
sessions for an initial appointment compared to a follow-up appointment. These 
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Figure 2.2 Most important aspects of a session for new patients. Participants selected the 





Figure 2.3 Most important aspects of a session for follow-up patients. Participants 



















































































































































































































































































































































Chi-square analysis was used to compare the most important aspects of a genetic 
counseling session for those patients with a diagnosis to those without a diagnosis. When 
compared across all of the aspects as a whole, there was a statistically significant 
difference between these two patient types for both new appointments as well as follow-
up appointments (p < .01).  
2.4.4 Resources for patients on the diagnostic odyssey. Participants were also 
asked about the different resources they provide to patients on a diagnostic odyssey. 
These results are displayed in Figure 2.4. Most participants (n = 41, 65%) reported 
providing resources general to the patient’s working diagnosis or main symptoms.  
 
Figure 2.4 Resources provided to undiagnosed patients’ families. Participants selected all 
types of resources they provide. 
 
Of the themes identified in the “Other” category, four participants utilize their 
institutional resources, including social workers or care coordinators, and three refer 
patients to appropriate research studies. Participants identified the group SWAN as being 







































































































































Genomics Institute, the National Organization for Rare Disorders (NORD), the Manton 
Center for Orphan Diseases, and In Need of a Diagnosis as additional resources for this 
particular patient population. The majority of participants (n = 55, 87%) felt that there is 
a need for more resources that specifically pertain to undiagnosed patients. 
2.4.5 Perceived purpose of a diagnosis. The genetic counselors’ perceptions of 
how a diagnosis benefits parents was assessed using the benefits cited by parents in 
previous literature, as well as which factors counselors find to be most helpful to parents 
(Rosenthal et al., 2001). The results are depicted in Figure 2.5. Chi-square analysis of the 
overall group of responses showed a statistically significant difference between the 
factors that counselors believe parents are hoping for compared to those that the genetic 
counselors believe are most helpful to the parents (p < .01). 
 
Figure 2.5 Perceived purpose of a diagnosis. The reported numbers add up to over 100% 






























Participants were asked to provide strategies they have found helpful for families 
with a child on a diagnostic odyssey and their responses fell into three main categories: 
emotional, informational, and support strategies.  
Emotional strategies were identified by 28 of 41 participants and included 
maintaining hope, exhibiting empathy, and acknowledging the family’s struggles and 
frustrations. Additionally, preparing the family for the potential of the diagnostic odyssey 
and managing their expectations early in the process is beneficial. Other emotional 
strategies included being optimistic and normalizing the experience to help the family 
know they are not alone in the diagnostic odyssey. 
 Informational strategies were identified by 20 of 41 participants and included 
educating families about the improving knowledge base and technology to provide hope 
for the future. Additionally, participants reported that it is beneficial to remind families 
that a genetic diagnosis will likely not change the child’s medical management or 
treatment options.  
Finally, support strategies were identified by eight of 41 participants and included 
directing the family to SWAN, assisting them with school accommodations and access to 
therapies, and connecting them with other families in similar situations. Two counselors 
reported not being sure of helpful strategies for families on the diagnostic odyssey. 
 Four themes were identified as limitations or barriers to assisting families on a 
diagnostic odyssey. The first theme was financial barriers, which included the cost of 
testing and lack of insurance coverage for genetic testing. Secondly, the informational 
factor included limitations in the testing itself and our current education and knowledge 
about various results, the lack of treatment if a diagnosis is found, and the potential lack 
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of information regarding the disease progression. The third theme was the emotional 
stress of the diagnostic odyssey, including patients feeling burnt out or losing interest 
from the long process and not returning for follow-up. The final theme was support, 
which included patients feeling that there is a lack of support when they do not have a 
diagnosis, a lack of specific resources, or social isolation. 
2.4.6 Impact of the diagnostic odyssey on pediatric genetic counselors. Genetic 
counselors reflected on the personal impact of interacting with patients on a diagnostic 
odyssey. The results were diverse and are summarized in Table 2.2. 
Table 2.2 Impact of the Diagnostic Odyssey on Genetic Counselors (N = 59) 
Question Response n (%) Themes: Example 
Do you feel 
personally affected 
when the genetic 
testing/evaluation 
does not reveal a 













Uncertainty: “I especially feel bad 
when families make family 
planning decisions based on the 
unknown risk of recurrence” 
 
Personal responsibility: “You feel 
like you let the family down” 
Do you feel 
personally affected 
when counseling a 
patient who has had 













Positive feelings: “If I didn’t feel 
personally affected – I wouldn’t be 
doing my job correctly. The key is 
to not let it impact your 
performance or your emotional 
health” 
 
Negative feelings: “Some families 
are desperately searching for an 
answer and you feel inadequate 
when you are unable to provide 
one” 
When a patient has an 
ongoing diagnostic 
odyssey, does this 
impact your 
counseling or ability 













Builds stronger rapport: “I feel 
closer to these families because we 
work so hard on research, support, 
etc” 
 
Strains in building rapport: 
“Families do sometimes blame me 
or our team” 
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 When asked about the utility of a positive genetic testing result for conditions 
with limited natural history information, most participants felt that a positive result was at 
least somewhat helpful or helpful (n =47, 80%), and 12 participants felt it was very 
helpful. Although everyone felt a positive result was at least somewhat helpful, 
participants reported both benefits and limitations of that result. Benefits included 
providing a label for the child’s condition and closure to the family, as well as 
eliminating blame the family may have been feeling and offering them relief. Other 
benefits included the ability to use the result for family planning purposes, and to focus 
the child’s medical management and open the door to additional resources and services. 
Finally, participants found it beneficial to share the hope that more information would 
become available in the future as similar results are identified in other children. 
 Eleven participants discussed the limitations of a positive result if there is not 
well-known natural history information for the condition. These participants reported that 
patients want a clear answer with specific management guidelines and prognostic 
information and they may feel disappointed that an answer does not mean there is an 
effective treatment to help their child.  
 For participants who felt personally affected by not finding a diagnosis for a 
patient after genetic testing, they described situations that fell into the themes of personal 
responsibility and uncertainty. Within the theme of personal responsibility, several 
participants reported feeling frustration, especially when they think there should be an 
underlying genetic cause for a child’s condition that was not identified by currently 
available testing. One participant recalled a patient for whom she could not identify a 
molecular mechanism: 
	 28 
I have one couple who have one daughter with an epileptic 
encephalopathy which we believe has a genetic basis, but we have yet to 
determine the molecular mechanism. The couple are understandably 
reluctant to consider another pregnancy without fully understanding the 
recurrence risks, and we have regular conversations about whether there 
is any additional testing available which may determine the genetic basis 
of their daughters epilepsy. It is frustrating both for myself and the couple 
that we are yet to provide them with the answers they seek. 
Participants also reported feeling disappointed and that they “let the family down” when 
they receive negative genetic test results and cannot provide additional information to the 
family regarding their child’s condition. However, four participants reported remaining 
hopeful that new clinical tests would be able to find the answers for their patients.  
 Most participants reported feeling frustrated all or some of the time when seeing 
the same patient over and over without a diagnosis (n = 47, 80%). Some participants (n = 
26) suggested strategies for coping with this frustration. The predominant strategies 
included remaining optimistic about the future (n = 11) and lengthening the amount of 
time between follow-up appointments to allow technology and knowledge to catch up 
and be more likely to provide additional information (n = 4). Other strategies included 
discussing their frustration with their colleagues or supervisors (n = 3) and utilizing de-
stressing techniques (n = 3). Feelings of frustration were not universal; two participants 
felt that not having a diagnosis “is not a big deal” and therefore coping strategies were 
not necessary. 
	 29 
 When asked about ways the diagnostic odyssey may impact the counseling or 
ability to build rapport with the family, counselors reported that it could both strain and 
strengthen the connection. Some counselors (n = 11) reported the odyssey as having a 
positive effect on rapport because they continued to follow the family over time and 
worked hard to research the child’s features and make every visit worthwhile. As one 
participant stated, “I actually think this is an opportunity for deeper rapport building, as 
we are able to see how a family deals with uncertainty over time and provide 
psychosocial support as needed.”  On the other hand, counselors (n = 13) reported that 
families start to feel that following up with genetics is not helpful and the family may 
distrust the expertise of genetics’ professionals because they cannot provide more 
information about their child’s condition. One example of this was stated as, “I feel like 
families lose faith and trust in you and your team when we continue to have normal 
results.”  
2.5 Discussion 
 The diagnostic odyssey affects a significant portion of pediatric genetic 
counseling patients, although there is little information on genetic counseling practices 
for this patient population. Based on a survey of 63 pediatric genetic counselors, this 
study identified current practices, including communication and follow-up methods with 
patients, resources that are provided to patients, important aspects of the genetic 
counseling session, perceived purpose of a diagnosis, and current limitations to providing 
information to patients and families on the diagnostic odyssey. Additionally, responses 
revealed the impact of the diagnostic odyssey on pediatric genetic counselors.  
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Our sample of pediatric genetic counselors was representative of the genetic 
counselor population as a whole in regards to gender, age, and ethnicity, as described by 
the National Society of Genetic Counselors (2014). The responses collected from 
participants supported some features of genetic counseling sessions that we expected to 
be true. This includes the fact that genetic counseling sessions differ for patients with and 
without a diagnosis. 
2.5.1 Definition of a diagnosis and the diagnostic odyssey. There are a variety of 
definitions of a diagnosis in the current literature, including a clinical or syndromic 
diagnosis, a molecular or genetic diagnosis, a working diagnosis, and others that are less 
commonly used. The research focus was on the diagnostic odyssey, which emphasizes 
the process of trying to identify a specific diagnosis, which may include one or more of 
the above terms. However, the definitions of these terms vary and may have different 
meaning to patients and professionals. Based on the literature and data recorded in this 
study, it seems to be difficult to identify the true definition or categories of diagnoses. It 
is also difficult to discern which definitions and aspects are most important to patients, 
their families, and healthcare professionals. While it may be difficult to define a final 
diagnosis, participants in this study had a shared understanding of the concept of the 
diagnostic odyssey and expressed several consistent themes. 
2.5.2 Communication with families on the diagnostic odyssey. Many of the 
current follow-up and communication methods being utilized by our participants place 
the responsibility of receiving updated information on the patients and their families. 
Examples of this patient responsibility include returning for follow-up appointments or 
contacting their healthcare professionals about new discoveries or testing options. 
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However, some participants reported that other methods of communication may also be 
beneficial, most of which place some of the responsibility back onto the genetics team, 
such as sending out newsletters or messages via a secure patient portal.  
Not all participants felt this issue had a clear answer. A few genetic counselors did 
not believe that it was their role to contact patients between appointments, even if they 
may have the time or ability to do so. However, according to Lipinski et al. (2006), 
parents of patients want to be informed when new technologies are available that may be 
beneficial in their search for an answer. This may lead genetic counselors to establish a 
method for sharing this responsibility of communication between the healthcare team and 
patients. 
2.5.3 Resources for patients on the diagnostic odyssey. Some participants cited 
the importance of normalizing the diagnostic odyssey and that many families do not 
receive the answer for which they are looking. While normalizing is reported to be 
helpful, less than half of participants reported referring patients to support groups 
specifically for patients on a diagnostic odyssey or connecting these families. Genetic 
counselors should be aware of support opportunities for these patients and seek to utilize 
them. Genetic counselors may consider working with their own patients to create a local 
network of families on a diagnostic odyssey. While the list of medical symptoms may not 
be similar, the process and feelings about a diagnosis likely are similar. As Ainbinder et 
al. (1998) reported, parent-to-parent support is a beneficial tool for these families, and 
finding a match between parents is crucial. The connection of being on a diagnostic 
odyssey may be sufficient for a successful relationship, and help show families that they 
are not alone in their search for an answer. 
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Additionally, participants reported wanting more resources for patients without a 
diagnosis. In addition to referring patients to identified groups such as SWAN and 
NORD, pediatric genetic counselors are well-equipped to play a role in developing 
resources that may be helpful to these families. Genetic counselors may work with 
affected families to create brochures, newsletters, or informational websites specific to 
the diagnostic odyssey and their locale. 
2.5.4 Impact of the diagnostic odyssey. Many participants discussed the personal 
impact they feel from patients on the diagnostic odyssey. Importantly, genetic counselors 
feel responsible for finding an answer for patients and their families, and when they are 
unable to identify an answer, they feel frustration, disappointment, and a sense of 
hopelessness. However, finding a diagnosis is not listed as one of the elements of the 
genetic counseling process: 
Genetic counseling is a process of helping people understand and adapt to the 
medical, psychological and familial implications of genetic contributions to 
disease. This process integrates: 
• Interpretation of family and medical histories to assess the chance of 
disease occurrence or recurrence. 
• Education about inheritance, testing, management, prevention, resources 
and research. 
• Counseling to promote informed choices and adaptation to the risk or 
condition. (National Society of Genetic Counselors, 2015) 
Some of these elements may be more difficult to accomplish when a patient does not 
have a diagnosis, such as education about inheritance and assessment of disease 
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occurrence or recurrence, but most are still possible with knowledge simply of that 
patient’s current medical symptoms. As many counselors pointed out, managing 
expectations about the risk of the diagnostic odyssey can also be beneficial to the family, 
which is simply a different way of accomplishing the part of the process that is 
“counseling to promote… adaptation to the risk or condition” (National Society of 
Genetic Counselors, 2015). 
It is important that pediatric genetic counselors recognize their feelings regarding 
patients on the diagnostic odyssey and consider the variety of coping strategies discussed 
above. Although the diagnostic odyssey can affect genetic counselors personally, they are 
still able to accomplish their goals and provide information to families. It is also 
important to acknowledge that genetics is a growing field in healthcare with new 
information being discovered everyday, but to remain realistic and manage the families 
and their personal expectations. In remaining self-aware of one’s own feelings, genetic 
counselors can remain unbiased during sessions and eliminate countertransference while 
still expressing empathy and understanding toward the patient’s experiences. 
2.5.5 Study limitations. This study surveyed only a small portion of currently 
practicing pediatric genetic counselors; therefore, the results may not be generalized to all 
pediatric genetic counselors or pediatric genetics clinics. We did not assess the 
counselors’ work setting, which may have an impact on the number of patients who are 
on a diagnostic odyssey and therefore influence the participants’ experiences and 
perspectives.  
 The majority of the questionnaire was created based on previous research 
reporting patients’ perspectives and experiences as well as the outlined responsibilities of 
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genetic counselors. Responses may have been limited or biased by these specific options 
for some questions, although respondents had the option to provide additional 
suggestions in the “Other” selection. We may have identified additional themes had the 
study been completed via a primarily qualitative method. 
2.5.6 Future research. As discussed above, additional information could be 
collected from interviews with pediatric genetic counselors to determine their unbiased 
views about the diagnostic odyssey. This may reveal themes that previous research with 
genetics patients has not displayed up to this point. It would also be interesting to survey 
or interview both genetic counselors and their patients on a diagnostic odyssey to 
compare their desires and perspectives of the process. This would likely provide the 
greatest insight into the diagnostic odyssey and reveal any discrepancies between 
genetics professionals and their patients. 
 Furthermore, exploring the roles and responsibilities of genetic counselors further 
may be informative to identify what patients want from genetic counselors when they are 
on a diagnostic odyssey and what the counselors believe is their role in the process. This 
may help clarify the discrepancy between communication with patients and available 
resources and if genetic counselors should help provide additional resources or 
information to patients between appointments. 
2.6 Conclusions 
Patients on a diagnostic odyssey make up a significant portion of patients seen in 
genetics clinics. While patients on a diagnostic odyssey are common, it is challenging for 
pediatric genetic counselors to incorporate new technologies, available resources, and 
research into practice without having published recommendations or guidelines on how 
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to do so. The aim of this study was to investigate current genetic counseling practices for 
patients on a diagnostic odyssey and the impact of the diagnostic odyssey on pediatric 
genetic counselors.  
While about a third of pediatric genetic counselors already have a method of 
tracking undiagnosed patients, others report the need for further tracking of undiagnosed 
patients. Pediatric genetic counselors identified strategies to share the responsibility of 
follow-up between the patient and the healthcare provider, including patients continuing 
to follow-up with their clinic while also receiving newsletters or personal messages from 
their providers. Genetic counselors also identified a need for more resources specifically 
for patients on a diagnostic odyssey, potentially provided by the counselors themselves 
via support groups within their institution or electronic groups and resources.  
A wide range of themes was identified to describe the impact that the diagnostic 
odyssey has on pediatric genetic counselors as well as limitations to helping the patients 
and their families. Many counselors reported feeling frustrated and disappointed when 
they are unable to provide the answers and information that parents desire. There are 
many coping strategies to help address these feelings, and they should be utilized to avoid 
countertransference. However, these feelings can be useful to acknowledge because they 
may help build rapport between the genetics professionals and the family by showing 
empathy and understanding for the family’s situation. 
It is important for pediatric genetic counselors to recognize the difficulties 
experienced by patients and families on a diagnostic odyssey and listen to what the 
family needs. Genetic counselors should focus each session on the family’s goals while 
presenting new genetic information and testing as appropriate for each patient. Genetic 
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counselors play a crucial role in the diagnostic odyssey and have an opportunity to make 
the complex process an easier one by communicating with patients and remaining open 
and honest with the families they assist. 
  
	 37 
Chapter 3: Conclusions 
Patients on a diagnostic odyssey make up a significant portion of patients seen in 
genetics clinics. While patients on a diagnostic odyssey are common, it is challenging for 
pediatric genetic counselors to incorporate new technologies, available resources, and 
research into practice without having published recommendations or guidelines on how 
to do so. The aim of this study was to investigate current genetic counseling practices for 
patients on a diagnostic odyssey and the impact of the diagnostic odyssey on pediatric 
genetic counselors.  
While about a third of pediatric genetic counselors already have a method of 
tracking undiagnosed patients, others report the need for further tracking of undiagnosed 
patients. Pediatric genetic counselors identified strategies to share the responsibility of 
follow-up between the patient and the healthcare provider, including patients continuing 
to follow-up with their clinic while also receiving newsletters or personal messages from 
their providers. Genetic counselors also identified a need for more resources specifically 
for patients on a diagnostic odyssey, potentially provided by the counselors themselves 
via support groups within their institution or electronic groups and resources.  
A wide range of themes was identified to describe the impact that the diagnostic 
odyssey has on pediatric genetic counselors as well as limitations to helping the patients 
and their families. Many counselors reported feeling frustrated and disappointed when 
they are unable to provide the answers and information that parents desire. There are 
many coping strategies to help address these feelings, and they should be utilized to avoid 
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countertransference. However, these feelings can be useful to acknowledge because they 
may help build rapport between the genetics professionals and the family by showing 
empathy and understanding for the family’s situation. 
It is important for pediatric genetic counselors to recognize the difficulties 
experienced by patients and families on a diagnostic odyssey and listen to what the 
family needs. Genetic counselors should focus each session on the family’s goals while 
presenting new genetic information and testing as appropriate for each patient. Genetic 
counselors play a crucial role in the diagnostic odyssey and have an opportunity to make 
the complex process an easier one by communicating with patients and remaining open 
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Appendix A: Participant Invitation Email 
 
Dear NSGC member, 
  
Are you a pediatric genetic counselor? Do you see patients that are on a diagnostic 
odyssey? 
  
If so, you are invited to participate in a research study investigating your role in the 
diagnostic odyssey. One goal of the study is to understand current practices of pediatric 
genetic counselors for patients on a diagnostic odyssey. We also hope to investigate the 
impact that the diagnostic odyssey has on pediatric genetic counselors. 
  
Participation in this study is open to all pediatric genetic counselors. The study consists 
of an anonymous online survey that should take no longer than 20-30 minutes to 
complete. Participation is voluntary, and you may withdraw at any point. 
  
If you are interested in participating in this survey, please follow the link below: 
https://www.surveymonkey.com/r/N3SL3CZ 
  
If you have any questions or comments, please feel free to contact me by email at 
amy.cordell@uscmed.sc.edu or the University of South Carolina faculty advisor, Emily 
Jordon, at emily.jordon@uscmed.sc.edu. 
  
Thank you for your consideration, 
  
Amy Cordell Wardyn, B.S. 
University of South Carolina 
School of Medicine 
Genetic Counseling Program 
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Appendix B: Participant Introductory Letter 
 
University of South Carolina School of Medicine 
Genetic Counseling Program 
Dear Potential Participant, 
 
You are invited to participate in a graduate research study focusing on pediatric 
genetic counselors and undiagnosed patients. I am a graduate student in the genetic 
counseling program at the University of South Carolina School of Medicine. My research 
investigates the current practices of pediatric genetic counselors for patients on a 
diagnostic odyssey. The research involves completing one online survey. 
 
The surveys attempt to gather information about current practices and the impact 
of undiagnosed patients on pediatric genetic counselors. If you do not wish to answer a 
certain question, please skip that question and continue with the rest of the survey. 
 
All responses gathered from the surveys will be kept anonymous and confidential. 
We do not ask for your name or contact information. The results of this study might be 
published or presented at academic meetings; however, participants will not be identified. 
 
Your participation in this research is voluntary. By completing the survey, you are 
consenting that you have read and understand this information. At any time, you may 
withdraw from the study by not completing the survey. 
 
Thank you for your time and consideration to participate in this survey. Your 
responses may help inform recommendations for counseling patients while on their 
diagnostic odyssey. If you have any questions regarding the research, you may contact 
either myself or my faculty advisor, Emily Jordon, MS, CGC, using the contact 
information below. If you have any questions about your rights as a research participant, 
you may contact the Office of Research Compliance at the University of South Carolina 
at (803) 777-7095. 
 
Amy Wardyn, B.S. 
Genetic Counselor Candidate 
University of South Carolina School of 
Medicine 
USC Genetic Counseling Program 
Two Medical Park, Suite 103 





University of South Carolina School of 
Medicine 
USC Genetic Counseling Program 
Two Medical Park, Suite 103 




Appendix C: Participant Questionnaire 
 
1. Please provide your definition of a diagnostic odyssey. 
_______________________________________ 
Definition of a diagnosis: Providers working in pediatric genetics clinics may make 
diagnoses in a number of different ways, such as based on clinical symptoms or genetic 
testing. For the purposes of this survey, we are focusing on patients on a diagnostic 
odyssey. These patients have a collection of symptoms that the medical team believes to 
be related, but a single unifying cause or descriptive label has not been identified. The 
patients may be collectively referred to as “undiagnosed”. 








3. Please estimate the percentage of your pediatric patients that remain undiagnosed after 












5. If so, what method(s) does your clinic use to record undiagnosed patients for future 
identification? _______________________________________ 
6. If you answered no to question 4, do you believe your clinic needs a method of 
recording undiagnosed patients for future identification? 
o Yes 
o No 
7. How do you and other genetics professionals in your clinic incorporate new 
technologies (such as new tests) into practice for undiagnosed patients? 
o You call undiagnosed patients when new discoveries are made if they may apply 
to their specific case 
o You share new testing information with the patient when they return for their 
scheduled follow-up appointment 
o You encourage the patient to contact the clinic between follow-up appointments 
to check on new testing developments 
o Other (please specify) _______________________________________ 
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8. Do you think another method of communication for new genetic tests or novel gene 
discoveries would better benefit patients on their diagnostic odyssey? 
o Yes 
o No 
9. If you answered yes above, please describe other methods of communication that you 
think would benefit patients on their diagnostic odyssey. 
_______________________________________ 
For each of the four patient populations listed below, please select the 3 aspects of a 
session you find most important. While we understand this will be dependent on each 
individual patient’s case, please do your best to answer in a way that is generalizable to 
most patients in each population. If you would like, feel free to make comments in 
question 14. 
10. New patients WITH a diagnosis 
o Interpretation/updating family history 
o Interpretation/updating medical history 
o Education about inheritance 
o Education about testing 
o Education about management of disorder or symptoms 
o Education about available resources 
o Education about current research 
o Counseling to promote informed choices 
o Counseling to promote psychological adaptation to the risk or condition 
11. Follow-up patients WITH a diagnosis 
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o Interpretation/updating family history 
o Interpretation/updating medical history 
o Education about inheritance 
o Education about testing 
o Education about management of disorder or symptoms 
o Education about available resources 
o Education about current research 
o Counseling to promote informed choices 
o Counseling to promote psychological adaptation to the risk or condition 
12. New patients WITHOUT a diagnosis 
o Interpretation/updating family history 
o Interpretation/updating medical history 
o Education about inheritance 
o Education about testing 
o Education about management of disorder or symptoms 
o Education about available resources 
o Education about current research 
o Counseling to promote informed choices 
o Counseling to promote psychological adaptation to the risk or condition 
13. Follow-up patients WITHOUT a diagnosis 
o Interpretation/updating family history 
o Interpretation/updating medical history 
o Education about inheritance 
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o Education about testing 
o Education about management of disorder or symptoms 
o Education about available resources 
o Education about current research 
o Counseling to promote informed choices 
o Counseling to promote psychological adaptation to the risk or condition 
14. For questions 10-13, please provide any additional comments here. 
_______________________________________ 
15. Please select all of the following that you provide to undiagnosed patients’ families. 
Each type of resource listed may include brochures, websites, referrals to support groups, 
or other resources. You are able to specify what these resources are in the following 
question. 
o Resources for patients specifically without a diagnosis 
o Resources general to the patient’s geographic location 
o Resources general to the patient’s working diagnosis/main symptoms 
o Internet group resources 
o Financial aid resources 
o None of the above 
o Other (please specify) _______________________________________ 
16. For the items you selected above, please elaborate on the specific resources you 
provide to patients. _______________________________________ 





18. If you are aware of any particular resources that specifically pertain to undiagnosed 
patients or patients continuing on their diagnostic odyssey, please list them here. 
_______________________________________ 
19. What do you think parents are hoping for in a diagnosis for their child? Please select 
your top 3 responses. 
o Label: to help with understanding and explaining the condition 
o Causation/etiology: to provide recurrence risk and/or explanation of how this 
happened 
o Prognosis: to prepare for the child’s future health, intellectual, or physical 
challenges 
o Treatment: to mitigate physical symptoms or improve functioning 
o Acceptance: to understand the permanence and natural history of the child’s 
condition 
o Social support: to connect with support groups, other parents, and to procure 
services 
o Other (please specify) _______________________________________ 
20. What aspects about a child receiving a diagnosis do you think are most helpful to 
their parents? Please select your top 3 responses. 
o Label: to help with understanding and explaining the condition 
o Causation/etiology: to provide recurrence risk and/or explanation of how this 
happened 
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o Prognosis: to prepare for the child’s future health, intellectual, or physical 
challenges 
o Treatment: to mitigate physical symptoms or improve functioning 
o Acceptance: to understand the permanence and natural history of the child’s 
condition 
o Social support: to connect with support groups, other parents, and to procure 
services 
o Other (please specify) _______________________________________ 
21. What are some strategies you have found helpful for families with a child on a 
diagnostic odyssey? _______________________________________ 
22. Please identify any limitations or barriers you have encountered in helping families 
who have a child on a diagnostic odyssey. _____________________________________ 
23. How helpful do you think a positive result from genetic testing, such as Whole 
Exome Sequencing (WES), is to parents of an undiagnosed child if there is no additional 
information to provide regarding natural history of the newly discovered disorder? 
Not at all helpful Somewhat helpful Helpful Very helpful 
 
24. Please elaborate on your response to question 23. 
_______________________________________ 
25. Do you feel personally affected when the genetic testing/evaluation does not reveal a 




26. If so, please describe a situation when you felt personally affected by not finding a 
diagnosis for a patient after genetic testing. ____________________________________ 




28. If so, please describe a situation when you felt personally affected counseling a 
patient on their diagnostic odyssey. _______________________________________ 





30. If you do find this repetition frustrating, please describe that situation and strategies 
you have used to cope with the frustration. _____________________________________ 
31. When a patient has an ongoing diagnostic odyssey, does this impact your counseling 
or ability to build rapport with the patient? 
o Yes 
o No 
32. If so, please describe the ways that the diagnostic odyssey may impact your 
counseling or ability to build rapport. _______________________________________ 
 33. How many years have you been working as a genetic counselor? 
o < 1 year 
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o 1-4 years 
o 5-9 years 
o 10-14 years 
o 15+ years 
34. How many years have you been working in clinical pediatric genetic counseling? 
o < 1 year 
o 1-4 years 
o 5-9 years 
o 10-14 years 
o 15+ years 
35. Are you a certified genetic counselor? 
o Yes 
o No 
o Board eligible 












38.  Age 
o 20-29 years 
o 30-39 years 
o 40-49 years 
o 50+ years 
39. Ethnicity 
o Caucasian 
o African American 
o Hispanic 
o Native American 
o Asian/Pacific Islander 
o Other (please specify) _______________________________________ 
You have reached the end of the survey. Thank you for your participation. 
 
